TrueParallel, Author at AskBio - Page 4 of 4

Libbie Mansell Joins AskBio as SVP Regulatory Affairs Posted on July 23, 2020 (July 23, 2020) by TrueParallel in News
AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing System Posted on June 23, 2020 (August 6, 2020) by TrueParallel in News
AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome Posted on March 18, 2020 (August 6, 2020) by TrueParallel in News
Tim Kelly Joins AskBio as President of Manufacturing to Lead AAV Vector Production for Gene Therapy Posted on March 12, 2020 (March 12, 2020) by TrueParallel in News
CYTOO and AskBio Enter into Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder Posted on February 28, 2020 (February 28, 2020) by TrueParallel in News
AskBio Appoints Anna Tretiakova, PhD, as Senior Vice President of Product Development Posted on February 19, 2020 (May 28, 2020) by TrueParallel in News
11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals | Lisbon Posted on February 17, 2020 (February 20, 2020) by TrueParallel in Event
AskBio Launches AskFirst™ Patient Advocacy Program to Educate and Support Participants in Gene Therapy Clinical Trials Posted on January 29, 2020 (May 28, 2020) by TrueParallel in News
AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease Posted on December 19, 2019 (May 28, 2020) by TrueParallel in News
AskBio and AveXis Finalize License Posted on June 17, 2015 (June 30, 2020) by TrueParallel in News